CD4+, CD8+ T cells, macrophages, and DCs expressing the receptors of these chemokines were recruited into ESCC (41–44), where these cells were regulated by complex signaling from the regional tumor microenvironment and presented diverse capabilities participating in pro- or antitumor immune response. The gene discussed is CD8A; the disease is neoplasm.